Chirality-Functionalized Covalent Organic Frameworks for Enantioselective Neuroprotection with Restored Neuroactive Signaling in Alzheimer’s Disease
ACS Nano · 10.11.2026 · 20 (44) · 29550-29563
DOI: 10.1021/acsnano.6c08616 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 26.10.2026. Verfasst von Lulu He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technolog…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents, Nanoparticles, Neuroprotection. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is driven by amyloid-β (Aβ) accumulation and a cascade of interconnected neurotoxic events, including oxidative stress, glutamate excitotoxicity, calcium dysregulation, and impaired neuroactive ligand–receptor signaling. To address the multifactorial nature of AD pathology, chiral d- or l-cysteine-functionalized covalent organic framework (COF) nanoparticles are developed as a multitarget nanotherapeutic platform. Both enantiomers effectively inhibit Aβ aggregation, scavenge reactive oxygen species, reduce extracellular glutamate levels, and attenuate calcium dysregulation. In parallel, d/l-Cys-COFs rescue compromised neuroactive ligand–receptor signaling, as evidenced by normalized expression of neuropeptide Y and brain-derived neurotrophic factor. In transgenic AD mice, d/l-Cys-COF treatment significantly improves memory and cognitive performance. Notably, the d-enantiomer affords superior neuroprotection through enhanced suppression of pathological intracellular calcium overload, whereas restoration of neuroactive ligand–receptor signaling remains chirality-independent. These findings identify chirality as a key design element for multitarget nanotherapeutics against AD, with enantioselective efficacy arising primarily from differential regulation of calcium dysregulation and shared restoration of neuroactive signaling contributing to the overall therapeutic benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Zhejiang Engineering Research Center for Biomedical…
- University of Chinese Academy of Sciences, Beijing100049, China.
ORCID-Profile: Lulu He, Zhen He, Hongying Bao, Aiguo Wu, Juan Li
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
He, L., He, Z., Yu, Z., Bao, H., Zhang, Q., Duan, X., Wu, A., & Li, J. (2026). Chirality-Functionalized Covalent Organic Frameworks for Enantioselective Neuroprotection with Restored Neuroactive Signaling in Alzheimer’s Disease. ACS Nano, 20(44), 29550-29563. https://doi.org/10.1021/acsnano.6c08616
Vancouver
He L, He Z, Yu Z, Bao H, Zhang Q, Duan X, et al. Chirality-Functionalized Covalent Organic Frameworks for Enantioselective Neuroprotection with Restored Neuroactive Signaling in Alzheimer’s Disease. ACS Nano. 2026;20(44):29550-29563. doi:10.1021/acsnano.6c08616
BibTeX
@article{He2026,
author = {He, Lulu and He, Zhen and Yu, Zhangcong and Bao, Hongying and Zhang, Qishu and Duan, Xiaolin and Wu, Aiguo and Li, Juan},
title = {Chirality-Functionalized Covalent Organic Frameworks for Enantioselective Neuroprotection with Restored Neuroactive Signaling in Alzheimer’s Disease},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {44},
pages = {29550--29563},
doi = {10.1021/acsnano.6c08616}
}
EUVIMED